Researchers discover how to overcome a treatment resistance mechanism in one of the most aggressive types of breast cancer



Researchers discover how to overcome a treatment resistance mechanism in one of the most aggressive types of breast cancer

A study has determined the role that fibroblasts, the cells that contribute to tissue formation, play in a tumor’s ability to generate resistance to the most common biological treatment for HER2. The paper demonstrates the ability of a new therapy, currently undergoing clinical trials, to promote a potent immune response by binding to the fibroblasts, enabling it to overcome resistance to anti-HER2 therapy in tumors with this cancer cell protection mechanism.

Materials provided by IMIM (Hospital del Mar Medical Research Institute). Note: Content may be edited for style and length.




Source link aaaaa

Related posts

18th March 2023

New combination of drugs works together to reduce lung tumors in mice

Read more
17th March 2023

Study offers a potential strategy to improve T cell therapy in solid tumors

Read more
17th March 2023

Researchers chart a course for understanding, preventing, and treating young-onset colorectal cancer

Read more